Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 Jan;75(1):1-6.
doi: 10.1111/bcp.12030.

Editors' pick 2012

Lionel D Lewis, Andrew Somogyi, Yoon K Loke, Albert Ferro, Adam F Cohen, James M Ritter
Editorial

Editors' pick 2012

Lionel D Lewis et al. Br J Clin Pharmacol. 2013 Jan.
No abstract available

PubMed Disclaimer

References

    1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95. - PubMed
    1. Chew SC, Sandanaraj E, Singh O, Chen X, Tan EH, Lim WT, Lee EJ, Chowbay B. Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients. Br J Clin Pharmacol. 2012;73:606–618. - PMC - PubMed
    1. Lewis LD, Miller AA, Owzar K, Bies RR, Markova S, Chen J, Kroetz D, Egorin MJ, McLeod HL, Ratain MJ. The relationship of polymorphisms in ABCC2 and SLCO1B3 to docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance) Pharmacogenet Genomics. 2012 (in press). DOI: 10.1097/FPC.0b013e32835b16d8. - DOI - PMC - PubMed
    1. de Graan AJ, Lancaster CS, Obaidat A, Hagenbuch B, Elens L, Friberg LE. Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel. Clin Cancer Res. 2012;18:4433–4440. - PMC - PubMed
    1. Etienne-Grimaldi MC, Bennouna J, Formento JL, Douillard JY, Francoual M, Hennebelle I, Chatelut E, Francois E, Faroux R, El Hannani C, Jacob JH, Milano G. Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan. Br J Clin Pharmacol. 2012;73:776–785. - PMC - PubMed

Publication types

MeSH terms

Substances